Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 8Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Neoplasm Metastasis 1Breast Neoplasms 1Brain Neoplasms 1Advanced Solid Tumors 1Advanced Cancers 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 31Paclitaxel 26Radiotherapy 23Bevacizumab 19Erlotinib Hydrochloride 16Cisplatin 14Gemcitabine 12Gefitinib 11Docetaxel 11Taxes 9Pemetrexed 9Etoposide 5pegfilgrastim 4Radiotherapy, Conformal 4Radiation 4Neoadjuvant Therapy 4Chemotherapy, Adjuvant 4Cetuximab 4Vinorelbine 3Amplified Fragment Length Polymorphism Analysis 3Topotecan 2Thalidomide 2Sorafenib 2Radiosurgery 2Pharmacogenomic Testing 2Nivolumab 2Magnetic Resonance Spectroscopy 2Irinotecan 2Gene Expression Profiling 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Bronchiolo-Alveolar × satraplatin × Clear all
NCT00093132 2012-08-17

Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy

Agennix

Phase 1/2 Terminated
20 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡